OHC Recognized By ASCO’s Conquer Cancer Foundation For Excellence In Clinical Trials Research
We’d like to share some incredible news with you! Here’s the news release we’re sending to media throughout the country telling them about the great news.
CINCINNATI, Ohio – OHC, the region’s only independent cancer practice and premier provider of treatments for adult cancer and complex blood disorders, is one of only six community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for its commitment to high-quality clinical trials programs.
“Thank you to our physicians, research staff and clinical staff for their unwavering dedication to always put our patients first with compassionate and leading cancer care,” said Dr. Waterhouse, OHC’s Research Program Medical Director. “It’s an honor to be recognized for improvement of cancer care through clinical research in a community-based setting.”
Practices were selected to receive the award based on several different criteria, which emphasize high patient accrual in clinical trials by overcoming barriers to enrollment. In 2014, 169 patients enrolled in clinical trials at OHC, and ongoing trials continue to further this commitment to high-quality research in more than 15 disease types and more than 70 open to enrollment trials. Preference was also given to practices with clinical trials programs that serve and connect with underrepresented populations in their communities.
The Clinical Trials Participation Award is funded through the Conquer Cancer Foundation of ASCO with the generous support of the Coalition of Cancer Cooperative Groups, which has supported the award since it was established in 2003.
“The Conquer Cancer Foundation of the American Society of Clinical Oncology is pleased to recognize OHC with the Clinical Trials Participation Award for providing local patients with access to high-quality clinical research that will help achieve groundbreaking advancements in cancer care,” said W. Charles Penley, MD, FASCO, Chair of the Conquer Cancer Foundation Board of Directors.
For more information regarding clinical trial participation at OHC please contact Nicole Given at 1-800-710-4674 ext. 27110, or visit www.ohcare.com for a complete list of available clinical trials. To learn more about the Conquer Cancer Foundation, please visit www.conquercancerfoundation.org.
For more than 30 years, OHC has served as the region’s premier provider of treatments for adult cancer and complex blood disorders, offering a wide range of services, state-of-the-art treatments and technologies. OHC puts patients first by delivering leading-edge, compassionate, and convenient care, tailored to meet a patient’s medical and personal needs. With more than 70 physicians and advanced practice providers, OHC treats nearly every form of adult cancer and complex blood disorders with medical, radiation and gynecologic oncology specialists. OHC offers clinical research trials in cutting-edge protocols and the most experienced adult blood and marrow transplant center in Cincinnati. With neighborhood locations throughout the tri-state area, OHC is one of the largest independent oncology practices in the United States. For more information visit www.ohcare.com.
About the Conquer Cancer Foundation
The Conquer Cancer Foundation (CCF) was created by the world’s foremost cancer doctors of the American Society of Clinical Oncology to seek dramatic advances in the prevention, treatment and cures of all types of cancer. Toward the vision of a world free from the fear of cancer, CCF works to conquer this disease by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, and by improving the quality of care and access to care, enhancing the lives of all who are touched by cancer. For more information, visit www.conquercancerfoundation.org.
Cover Image: Our feature image shows (L to R) OHC Chief Clinical Officer Ronda Bowman, Medical Oncologist and Principle Investigator Dr. Patrick Ward, Chair of Clinical Research Dr. David Waterhouse, and Research Department Director Lynnetta Hart, key members of the OHC Clinical Trials Research Program, standing proudly with this prestigious award.